An investing gold rush is coming for psychedelics. One line from a neuroscientist on their life-changing power explains why.
- Following the cannabis boom, psychedelics investing is just getting going.
- The clinical studies of the drugs point to them being life-changing.
- Visit Business Insider's homepage for more stories.
Psychedelic comes from the Greek for "mind manifests."
Signs point to a whole lot of minds manifesting soon.
The first-ever venture capital firm dedicated to psychedelics just launched. Investors claim it's the "next wave" after the cannabis boom, which has quickly turned into a $50 billion industry. Often thought of as a party drug, a wave of research is finding that in clinical settings, the hallucinogens can be tremendously therapeutic in the way they reshape (self) perception.
A while back, I interviewed Enzo Tagliazucchi, now at the Goethe University in Germany, one of the neuroscientists driving the research revolution in psychedelics.
He explained to me that a psychedelic experience, like with LSD or psilocybin (the active ingredient in "magic mushrooms"), has the power of "extracting the patient from his or her usual patterns of thought," which in turn allows them to contemplate "them from a vantage point."
The category of drugs has been used with many clinical populations, including people with substance dependencies or mood disorders. Perhaps most poignantly, it's been shown to be a powerful treatment for people facing terminal cancer, research that reveals one of the key mechanisms by which the drugs help people. (Still, research in the US remains woefully slim - the government lists psychedelics as Schedule 1 drugs, making them illegal for consumption, possession, or medical study.)
Patients go through what's technically called "ego dissolution," and it's a life-changing experience.
Tagliazucchi continued:
And with that, everything can change.
How to change your mind, indeed.
